Global Histone Deacetylase 6 Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Histone Deacetylase 6 Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Histone Deacetylase 6 Market Size Growth Rate by Product
  • 1.4.2 Citarinostat
  • 1.4.3 CKD-504
  • 1.4.4 ACY-738
  • 1.4.5 HG-3001
  • 1.4.6 MPT-0B291
  • 1.4.7 Ricolinostat
  • 1.4.8 Others
• 1.5 Market by End User
  • 1.5.1 Global Histone Deacetylase 6 Market Size Growth Rate by End User
  • 1.5.2 CNS Lymphoma
  • 1.5.3 Colon Cancer
  • 1.5.4 Huntington Disease
  • 1.5.5 Inflammation
  • 1.5.6 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Histone Deacetylase 6 Market Size
  • 2.1.1 Global Histone Deacetylase 6 Revenue 2014-2025
  • 2.1.2 Global Histone Deacetylase 6 Sales 2014-2025
• 2.2 Histone Deacetylase 6 Growth Rate by Regions
  • 2.2.1 Global Histone Deacetylase 6 Sales by Regions
  • 2.2.2 Global Histone Deacetylase 6 Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Histone Deacetylase 6 Sales by Manufacturers
  • 3.1.1 Histone Deacetylase 6 Sales by Manufacturers
  • 3.1.2 Histone Deacetylase 6 Sales Market Share by Manufacturers
  • 3.1.3 Global Histone Deacetylase 6 Market Concentration Ratio (CR5 and HHI)
• 3.2 Histone Deacetylase 6 Revenue by Manufacturers
  • 3.2.1 Histone Deacetylase 6 Revenue by Manufacturers (2014-2019)
  • 3.2.2 Histone Deacetylase 6 Revenue Share by Manufacturers (2014-2019)
• 3.3 Histone Deacetylase 6 Price by Manufacturers
• 3.4 Histone Deacetylase 6 Manufacturing Base Distribution, Product Types
  • 3.4.1 Histone Deacetylase 6 Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Histone Deacetylase 6 Product Type
  • 3.4.3 Date of International Manufacturers Enter into Histone Deacetylase 6 Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Histone Deacetylase 6 Sales by Product
• 4.2 Global Histone Deacetylase 6 Revenue by Product
• 4.3 Histone Deacetylase 6 Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Histone Deacetylase 6 Breakdown Data by End User

6 North America

• 6.1 North America Histone Deacetylase 6 by Countries
  • 6.1.1 North America Histone Deacetylase 6 Sales by Countries
  • 6.1.2 North America Histone Deacetylase 6 Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Histone Deacetylase 6 by Product
• 6.3 North America Histone Deacetylase 6 by End User

7 Europe

• 7.1 Europe Histone Deacetylase 6 by Countries
  • 7.1.1 Europe Histone Deacetylase 6 Sales by Countries
  • 7.1.2 Europe Histone Deacetylase 6 Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Histone Deacetylase 6 by Product
• 7.3 Europe Histone Deacetylase 6 by End User

8 Asia Pacific

• 8.1 Asia Pacific Histone Deacetylase 6 by Countries
  • 8.1.1 Asia Pacific Histone Deacetylase 6 Sales by Countries
  • 8.1.2 Asia Pacific Histone Deacetylase 6 Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Histone Deacetylase 6 by Product
• 8.3 Asia Pacific Histone Deacetylase 6 by End User

9 Central & South America

• 9.1 Central & South America Histone Deacetylase 6 by Countries
  • 9.1.1 Central & South America Histone Deacetylase 6 Sales by Countries
  • 9.1.2 Central & South America Histone Deacetylase 6 Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Histone Deacetylase 6 by Product
• 9.3 Central & South America Histone Deacetylase 6 by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Histone Deacetylase 6 by Countries
  • 10.1.1 Middle East and Africa Histone Deacetylase 6 Sales by Countries
  • 10.1.2 Middle East and Africa Histone Deacetylase 6 Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Histone Deacetylase 6 by Product
• 10.3 Middle East and Africa Histone Deacetylase 6 by End User

11 Company Profiles

• 11.1 Celgene Corp
  • 11.1.1 Celgene Corp Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Celgene Corp Histone Deacetylase 6 Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Celgene Corp Histone Deacetylase 6 Products Offered
  • 11.1.5 Celgene Corp Recent Development
• 11.2 Chong Kun Dang Pharmaceutical Corp
  • 11.2.1 Chong Kun Dang Pharmaceutical Corp Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Chong Kun Dang Pharmaceutical Corp Histone Deacetylase 6 Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Chong Kun Dang Pharmaceutical Corp Histone Deacetylase 6 Products Offered
  • 11.2.5 Chong Kun Dang Pharmaceutical Corp Recent Development
• 11.3 Curis Inc
  • 11.3.1 Curis Inc Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Curis Inc Histone Deacetylase 6 Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Curis Inc Histone Deacetylase 6 Products Offered
  • 11.3.5 Curis Inc Recent Development
• 11.4 HitGen LTD
  • 11.4.1 HitGen LTD Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 HitGen LTD Histone Deacetylase 6 Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 HitGen LTD Histone Deacetylase 6 Products Offered
  • 11.4.5 HitGen LTD Recent Development
• 11.5 Kancera AB
  • 11.5.1 Kancera AB Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Kancera AB Histone Deacetylase 6 Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Kancera AB Histone Deacetylase 6 Products Offered
  • 11.5.5 Kancera AB Recent Development
• 11.6 Karus Therapeutics Ltd
  • 11.6.1 Karus Therapeutics Ltd Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Karus Therapeutics Ltd Histone Deacetylase 6 Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Karus Therapeutics Ltd Histone Deacetylase 6 Products Offered
  • 11.6.5 Karus Therapeutics Ltd Recent Development
• 11.7 Medivir AB
  • 11.7.1 Medivir AB Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Medivir AB Histone Deacetylase 6 Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Medivir AB Histone Deacetylase 6 Products Offered
  • 11.7.5 Medivir AB Recent Development
• 11.8 Merck & Co Inc
  • 11.8.1 Merck & Co Inc Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Merck & Co Inc Histone Deacetylase 6 Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Merck & Co Inc Histone Deacetylase 6 Products Offered
  • 11.8.5 Merck & Co Inc Recent Development
• 11.9 Millennium Pharmaceuticals Inc
  • 11.9.1 Millennium Pharmaceuticals Inc Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Millennium Pharmaceuticals Inc Histone Deacetylase 6 Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Millennium Pharmaceuticals Inc Histone Deacetylase 6 Products Offered
  • 11.9.5 Millennium Pharmaceuticals Inc Recent Development
• 11.10 OnKure Inc
  • 11.10.1 OnKure Inc Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 OnKure Inc Histone Deacetylase 6 Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 OnKure Inc Histone Deacetylase 6 Products Offered
  • 11.10.5 OnKure Inc Recent Development
• 11.11 Quimatryx SL
• 11.12 Shuttle Pharmaceuticals LLC
• 11.13 Sigma-Tau SpA
• 11.14 SK Biopharmaceuticals Co Ltd

12 Future Forecast

• 12.1 Histone Deacetylase 6 Market Forecast by Regions
  • 12.1.1 Global Histone Deacetylase 6 Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Histone Deacetylase 6 Revenue Forecast by Regions 2019-2025
• 12.2 Histone Deacetylase 6 Market Forecast by Product
  • 12.2.1 Global Histone Deacetylase 6 Sales Forecast by Product 2019-2025
  • 12.2.2 Global Histone Deacetylase 6 Revenue Forecast by Product 2019-2025
• 12.3 Histone Deacetylase 6 Market Forecast by End User
• 12.4 North America Histone Deacetylase 6 Forecast
• 12.5 Europe Histone Deacetylase 6 Forecast
• 12.6 Asia Pacific Histone Deacetylase 6 Forecast
• 12.7 Central & South America Histone Deacetylase 6 Forecast
• 12.8 Middle East and Africa Histone Deacetylase 6 Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Histone Deacetylase 6 Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details